Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.9M Sell
1,295,949
-561,401
-30% -$22.6M 0.39% 74
2026
Q1
$61.5M Buy
1,857,350
+933,778
+101% +$30.4M 0.41% 69
2025
Q4
$30.2M Sell
923,572
-715,779
-44% -$17.6M 0.18% 105
2025
Q3
$29.2M Buy
1,639,351
+205,569
+14% +$2.98M 0.16% 116
2025
Q2
$15.6M Buy
1,433,782
+659,149
+85% +$8.64M 0.08% 138
2025
Q1
$14.3M Buy
+774,633
New +$14M 0.08% 142

Other funds holding AXGN

Wasatch Advisors's AXGN Position: Q2 2026 in Review

Wasatch Advisors reduced its Axogen (AXGN) stake by 30% in Q2 2026, selling an estimated $22.6M and leaving 1,295,949 shares worth $59.9M. The position accounts for 0.39% of the portfolio, ranked #74.

Wasatch Advisors first reported a position in AXGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $61.5M in Q1 2026. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Wasatch Advisors held 1,295,949 shares of Axogen worth $59.9M as of Q2 2026.
  • Wasatch Advisors sold 561,401 Axogen shares in Q2 2026, an estimated $22.6M.
  • Axogen made up 0.39% of Wasatch Advisors's portfolio in Q2 2026, its #74 holding.
  • Wasatch Advisors first reported a position in Axogen in Q1 2025 and has held it in 6 quarters since.
  • Wasatch Advisors's Axogen position peaked at $61.5M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.